Brief Update on Genomic Assays for Early Stage Breast Cancer

Adam Brufsky

Racial Disparities in Breast Cancer Screening and Diagnosis

UChicago Medicine

N. Chen

Management of Higher Risk eBC Including BRCAm, HER2- Subtypes

2024 ASCO® Annual Meeting Insights Hub

M. Dolezal

Identifying Breast Cancer Subtypes and Recurrence Risk: Multigene As…

Han-Byoel Lee

ESMO Breast 2024 Summary: "Breaking New Ground With CDK 4/6i - Case-…

Insights from ESMO Breast 2024 Annual Meeting

W. Janni

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

Clinical Overview of IO Development in ER+/HER2- BC

Laurence Buisseret

ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER…

2024 ASCO® Annual Meeting Insights Hub

E. Cobain

Neoadjuvant Chemo-IO for HR+/HER2- BC

Erin Cobain

Young Women With HR+/HER2- Breast Cancer: Options for Risk Assessment

University of Colorado Cancer Center

V. Borges